Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

NHS safeguarding webinar for pharmacy teams

The NHS England and NHS improvement (NHSE&I) Community Pharmacy and Safeguarding Teams will be hosting a webinar on Level 3 Safeguarding on Thursday (June 30) from 7-8pm.

“The one-hour webinar will be tailored specifically for staff working in community pharmacies and all members of the pharmacy team are invited to join the webinar (you do not need to have achieved Level 1 or 2 safeguarding to attend the webinar),” said the Pharmaceutical Services Negotiating Committee (PSNC).


Kenny Gibson MBE, National Head of Safeguarding at NHSE&I will be lead the webinar and talk about what Level 3 safeguarding involves including spotting the signs of abuse, signposting and making referrals. Kenny will also be joined by a panel of pharmacists who will reflect on real life safeguarding examples.

Commenting on the announcement of the webinar, Alastair Buxton, Director of NHS Services at PSNC, said: “Pharmacy teams are extremely well placed to identify people who may be vulnerable, including young adults and children. It is important that all pharmacy team members are aware of, and understand, potential signs of abuse, neglect or exploitation and how to respond in this situation.

“We have also seen over the last 18 months, how the sector has supported victims of domestic abuse by their successful involvement in the Ask for ANI scheme and Safe Spaces scheme, offering victims of domestic abuse a safe way to access support from the police or other domestic abuse support services.

“We would therefore encourage all community pharmacy team members to consider attending the webinar to build on their existing safeguarding knowledge and ensure they feel confident on how to deal with such matters as and when they arise.”

More For You

Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less
Pharma industry group unhappy with NHS drug pricing offer

The ABPI warned that £2 billion of potential investment could be under risk

Pic credit: istock

Pharma industry group unhappy with NHS drug pricing offer

The Association of the British Pharmaceutical Industry (ABPI) has rejected the UK government’s offer to cut the cost of NHS drugs pricing scheme as it felt it was inadequate.

The industry group warned that £2 billion of potential investment could be under risk and wanted prime minister Keir Starmer to intervene, The Times reports.

Keep ReadingShow less
Day Lewis celebrates 50 years of delivering care to communities

The Patel family at the unveiling of the commemorative plaque ceremony

Day Lewis celebrates 50 years of delivering care to communities

Day Lewis honoured "the people, purpose and partnerships" as it celebrated 50 years of service by unveiling a commemorative plaque at the company’s support office in Croydon.

As one of the UK’s largest independent pharmacy chains, Day Lewis has delivered trusted care to communities across the country since it was founded in 1975, by brothers Kirit and JC Patel, who was on hand to unveil the plaque.

Keep ReadingShow less
CPE said the committee’s discussions are fully shaped by pharmacy owners’ views and experiences

CPE said the committee’s discussions are fully shaped by pharmacy owners’ views and experiences

Pic credit: iStock

Pharmacy owners asked to share views on new contract and its financial implications

Pharmacy owners can share their thoughts on service developments and their financial security before the upcoming Community Pharmacy England (CPE) committee meeting to be held on June 25 and 26.

The new Community Pharmacy Contractual Framework (CPCF) was completed in March with the various service and regulatory changes still in progress.

Keep ReadingShow less
Cancer treatment impact

There have been supply issues with Creon since the summer of 2024

Pic credit: iStock

Cancer patients struggle amid digestive drug shortage

Pharmacists in the Channel Islands have revealed that there is a shortage of a drug used to support digestion in cancer patients.

Creon is a pancreatic enzyme replacement therapy (PERT), which helps people living with conditions such as cystic fibrosis, pancreatitis, and pancreatic cancer to digest food.

Keep ReadingShow less